Table 3.
Treatment, time point of treatment and patient outcome
| Case | Treatment | Time point of treatment after onset (d) | Outcome |
| 1 | Decreased immunosuppressant; G-CSF; IVIG | 16 | Death, infection |
| 2 | Decreased immunosuppressant; Methylprednisolone 80 mg × 10 d, then taper rapidly; G-CSF; IVIG | 6 | Death, gastrointestinal bleeding, infection, MOF |
| 3 | Decreased immunosuppressant; Methylprednisolone 80 mg × 10 d, then taper rapidly; G-CSF; ATG; IVIG | 16 | Death, gastrointestinal bleeding, infection, ARDS |
| 4 | Decreased immunosuppressant; Methylpredprednisolone impulse treatment, then taper; G-CSF | 5 | Death, gastrointestinal bleeding, infection, MOF |
| 5 | Discontinued immunosuppressant; Methylprednisolone impulse 480 mg/d, then taper; G-CSF; IVIG | 6 | Death, infection, gastrointestinal bleeding, respiratory failure |
| 6 | Non-specific treatment | ? | Death, infection |
G-CSF: Granulocyte colony-stimulating factor; IVIG: Intravenous immunoglobin therapy; MOF: Multiple organ failure; ARDS: Acute respiratory distress syndrome.